APA (7th ed.) Citation

Teufel, A., Gerken, M., Fürst, A., Ebert, M., Hohenthanner, I., & Klinkhammer-Schalke, M. (2020). Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with union for international cancer control stage II T4N0M0 colon cancer. European journal of cancer, 137, . https://doi.org/10.1016/j.ejca.2020.06.036

Chicago Style (17th ed.) Citation

Teufel, Andreas, Michael Gerken, Alois Fürst, Matthias Ebert, Ina Hohenthanner, and Monika Klinkhammer-Schalke. "Benefit of Adjuvant Chemotherapy in High-risk Colon Cancer: A 17-year Population-based Analysis of 6131 Patients with Union for International Cancer Control Stage II T4N0M0 Colon Cancer." European Journal of Cancer 137 (2020). https://doi.org/10.1016/j.ejca.2020.06.036.

MLA (9th ed.) Citation

Teufel, Andreas, et al. "Benefit of Adjuvant Chemotherapy in High-risk Colon Cancer: A 17-year Population-based Analysis of 6131 Patients with Union for International Cancer Control Stage II T4N0M0 Colon Cancer." European Journal of Cancer, vol. 137, 2020, https://doi.org/10.1016/j.ejca.2020.06.036.